Drug Manufacturing Company LLC (DMC), an Omani-based
Pharmaceutical company was established in 2010 to cater
competitive demands of the rapidly growing global drug markets.
The company is engaged in manufacturing of Antibiotic Active
Pharmaceutical Ingredients (APIs) in Sohar, Sultanate of Oman.
DMC is the fastest growing pharmaceutical company of Oman
with state-of-the-art manufacturing facilities designed, built and
operated with strict adherence to the current Good Manufacturing
Practice (cGMP) to meet and exceed international standards.
DMC has obtained all necessary approvals to produce and supply
of Cephalosporin APIs and in due course of time will go for
registration of DMF in regulated market.
Our goal is to provide high quality yet affordable Cephalosporin
APIs (Active Pharmaceutical Ingredients) to both branded and
generic companies worldwide. We aspire to become a strategic
business partner to numerous global renowned pharmaceutical
companies by providing timely and quality support for their
launches, business growth with transparency and standard
documentation procedures. Our commitment to addressing
supply chain challenges related to antibiotic APIs is DMC’s’ value to